Literature DB >> 27698024

Effect of HPV on cervical cancer screening in Alberta.

Marc Brisson1, Mélanie Drolet2, Élodie Bénard2, Aimée R Kreimer3.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27698024      PMCID： PMC5047822          DOI： 10.1503/cmaj.1150121

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  7 in total

1.  Dose-Related Differences in Effectiveness of Human Papillomavirus Vaccination Against Genital Warts: A Nationwide Study of 550,000 Young Girls.

Authors:  Maria Blomberg; Christian Dehlendorff; Carsten Sand; Susanne K Kjaer
Journal:  Clin Infect Dis       Date:  2015-05-05       Impact factor: 9.079

2.  Efficacy of fewer than three doses of an HPV-16/18 AS04-adjuvanted vaccine: combined analysis of data from the Costa Rica Vaccine and PATRICIA Trials.

Authors:  Aimée R Kreimer; Frank Struyf; Maria Rowena Del Rosario-Raymundo; Allan Hildesheim; S Rachel Skinner; Sholom Wacholder; Suzanne M Garland; Rolando Herrero; Marie-Pierre David; Cosette M Wheeler; Paula González; Silvia Jiménez; Douglas R Lowy; Ligia A Pinto; Caroline Porras; Ana Cecilia Rodriguez; Mahboobeh Safaeian; Mark Schiffman; John T Schiller; John Schussler; Mark E Sherman; F Xavier Bosch; Xavier Castellsague; Archana Chatterjee; Song-Nan Chow; Dominique Descamps; Francisco Diaz-Mitoma; Gary Dubin; Maria Julieta Germar; Diane M Harper; David J M Lewis; Genara Limson; Paulo Naud; Klaus Peters; Willy A J Poppe; Brian Ramjattan; Barbara Romanowski; Jorge Salmeron; Tino F Schwarz; Julio C Teixeira; Wiebren A A Tjalma
Journal:  Lancet Oncol       Date:  2015-06-09       Impact factor: 41.316

Review 3.  Human papillomavirus genotype distribution in low-grade cervical lesions: comparison by geographic region and with cervical cancer.

Authors:  Gary M Clifford; Rashida K Rana; Silvia Franceschi; Jennifer S Smith; Gerald Gough; Jeanne M Pimenta
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-05       Impact factor: 4.254

4.  Human papillomavirus types in 115,789 HPV-positive women: a meta-analysis from cervical infection to cancer.

Authors:  Peng Guan; Rebecca Howell-Jones; Ni Li; Laia Bruni; Silvia de Sanjosé; Silvia Franceschi; Gary M Clifford
Journal:  Int J Cancer       Date:  2012-03-20       Impact factor: 7.396

5.  Association of varying number of doses of quadrivalent human papillomavirus vaccine with incidence of condyloma.

Authors:  Eva Herweijer; Amy Leval; Alexander Ploner; Sandra Eloranta; Julia Fridman Simard; Joakim Dillner; Eva Netterlid; Pär Sparén; Lisen Arnheim-Dahlström
Journal:  JAMA       Date:  2014-02-12       Impact factor: 56.272

6.  Effect of human papillomavirus vaccination on cervical cancer screening in Alberta.

Authors:  Jong Kim; Christopher Bell; Maggie Sun; Gordon Kliewer; Linan Xu; Maria McInerney; Lawrence W Svenson; Huiming Yang
Journal:  CMAJ       Date:  2016-07-04       Impact factor: 8.262

7.  Proof-of-principle evaluation of the efficacy of fewer than three doses of a bivalent HPV16/18 vaccine.

Authors:  Aimée R Kreimer; Ana Cecilia Rodriguez; Allan Hildesheim; Rolando Herrero; Carolina Porras; Mark Schiffman; Paula González; Diane Solomon; Silvia Jiménez; John T Schiller; Douglas R Lowy; Wim Quint; Mark E Sherman; John Schussler; Sholom Wacholder
Journal:  J Natl Cancer Inst       Date:  2011-09-09       Impact factor: 13.506
  7 in total
  1 in total

1.  Starting cervical cancer screening at 25 years of age: the time has come.

Authors:  Cathy Popadiuk; Kathleen Decker; Cindy Gauvreau
Journal:  CMAJ       Date:  2019-01-07       Impact factor: 8.262
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.